Massachusetts Financial Services’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $837K | Sell |
|
|||||
|
2024
Q1 | $3.44M | Buy |
|
|||||
|
2023
Q4 | $2.63M | Sell |
|
|||||
|
2023
Q3 | $2M | Sell |
|
|||||
|
2023
Q2 | $4.37M | Sell |
|
|||||
|
2023
Q1 | $3.28M | Buy |
|
|||||
|
2022
Q4 | $4.47M | Buy |
|
|||||
|
2022
Q3 | $7.77M | Buy |
|
|||||
|
2022
Q2 | $6.44M | Sell |
|
|||||
|
2022
Q1 | $5.03M | Buy |
|
|||||
|
2021
Q4 | $7.49M | Sell |
|
|||||
|
2021
Q3 | $14.4M | Sell |
|
|||||
|
2021
Q2 | $16M | Buy |
|